期刊文献+

水杨酸钠微多孔渗透泵控释片的研制 被引量:2

Preparation of controlled porosity osmotic pump tablets of sodium salicylate
下载PDF
导出
摘要 目的制备水杨酸钠渗透泵控释片。方法考察各因素对药物释放的影响,采用均匀设计优化处方中影响药物释放的主要因素,预测最优处方,制备水杨酸钠渗透泵控释片,进行体外释放试验。结果最佳处方为:酒石酸用量30 mg,DEP用量23%,PEG用量3%,包衣增重4%,3批样品在12 h内体外释放符合零级过程。结论微孔膜控型水杨酸钠渗透泵控释片可行,可以达到设计的要求。 Objective To prepare controlled porosity osmotic pump tablets of sodium salicylate. Methods The factor influencing the drug release was investigated by the single factor investigation. Uniform design was used to get the quantitative relationship among the release rate and formula factors. Controlled porosity osmotic pump tablets of sodium salicylate was prepared and the release profile was determined in vitro, l^esults Three batches of controlled porosity osmotic pump tablets of sodium salicylate was prepared. The optimum formulation: tartaric acid, 30 rag; DEP, 23% ; PEG, 3% ; and the membrane thickness was 4% (as the percent of the core). The drug release pattern was in accordance with zero-order kinetics. Conclusion This method to prepare controlled porosity osmotic pump tablets of sodium salicylate was applicable with ideal controlled drug release.
出处 《广东药学院学报》 CAS 2008年第3期208-210,213,共4页 Academic Journal of Guangdong College of Pharmacy
关键词 微多孔渗透泵控释片 水杨酸钠 均匀设计 Controlled porosity osmotic pump tablets sodium salicylate uniform design
  • 相关文献

参考文献1

  • 1SAPNA N M, PRADEEP R V. Controlled porosity osmotic pump-based controlled release systems of pseudoephedrine I: Cellulose acetate as a semipermeable membrane [ J ]. Journal of Controlled Release, 2003,89:5 - 18.

同被引文献47

  • 1陈志鹏,朱家壁.口服渗透泵制剂的研究进展[J].国外医学(药学分册),2005,32(2):87-91. 被引量:15
  • 2刘龙孝,车斌杰,徐清.阿替洛尔单层芯渗透泵片的制备[J].药学学报,2006,41(5):457-460. 被引量:17
  • 3李红菊,张向荣,刘洪卓,陈存香,李三鸣.丙烯酸树脂RS100和丙烯酸树脂RL100混合包衣制备法莫替丁渗透泵控释片[J].沈阳药科大学学报,2007,24(7):398-401. 被引量:6
  • 4Li XD,Pan WS,Nie SF,et al.Studies on controlled release effervescent osmotic pump tablets from Traditional Chinese Medicine Compound Recipe[J].J Control Release,2004,96(3):359-367.
  • 5Okimoto K,Rajewski RA,Stella VJ,et al.Release of testosterone from an osmotic pump tablet utilizing (SBE) 7m -β-cyclodextrin as both a solubilizing and an osmotic pump agent[J].J Control Release,1999,58(1):29-38.
  • 6Okimoto K,Tokunaga Y,Ibuki R,et al.Applicability of (SBE)7m-β-CD in controlled-porosity osmotic pump tablets (OPTs)[J].Int J Pharm,2004,286(1/2):81-88.
  • 7Thombre AG,Appel LE,Chidlaw MB,et al.Osmotic drug delivery using swellable-core technology[J].J Control Release,2004,94(1):75-89.
  • 8Shanbhag A,Barclay B,Koziara J,et al.Application of cellulose acetate butyrate-based membrane for osmotic drug delivery[J].Cellulose,2007,14(1):65-71.
  • 9Verma RK,Krishna DM,Garg S.Formulation aspects in the development of osmotically controlled oral drug delivery systems[J].J Control Release,2002,79(1-3):7-27.
  • 10Prabakaran D,Singh P,Kanaujia P,et al.Effect of hydrophilic polymers on the release of diltiazem hydrochloride from elementary osmotic pumps[J].Int J Pharm,2003,259(1/2):173-179.

引证文献2

二级引证文献33

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部